Compounds > 1-hydroxy-3-amino-2-pyrrolidone

1-hydroxy-3-amino-2-pyrrolidone and apomorphine

1-hydroxy-3-amino-2-pyrrolidone has been researched along with apomorphine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Gnodde, HP; Schuiling, GA1
Gabor, R; Regunathan, S; Sourkes, TL1
Broxterman, HJ; Noach, EL; van Valkenburg, CF; Wijling, A1
Furuya, Y; Kagaya, T; Nishizawa, Y; Ogura, H1
Connelly, ST; Shepard, PD1

Other Studies

6 other study(ies) available for 1-hydroxy-3-amino-2-pyrrolidone and apomorphine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Involvement of catecholaminergic and cholinergic mechanisms in the pulsatile release of LH in the long-term ovariectomized rat.
    Neuroendocrinology, 1976, Volume: 20, Issue:3

    Topics: Animals; Apomorphine; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Catecholamines; Circadian Rhythm; Female; Luteinizing Hormone; Mecamylamine; Methyltyrosines; Neurotransmitter Agents; Ovary; Phenoxybenzamine; Pituitary Gland; Pituitary Gland, Anterior; Pyrrolidinones; Rats; Scopolamine

1976
Central regulation of adrenal tyrosine hydroxylase: interaction between dopamine and GABA systems.
    Neuropharmacology, 1989, Volume: 28, Issue:5

    Topics: Adrenal Glands; Adrenergic alpha-Agonists; Animals; Apomorphine; Azepines; Dopamine; Dopamine Agents; gamma-Aminobutyric Acid; Injections, Intraventricular; Male; Pyrrolidinones; Rats; Rats, Inbred Strains; Splanchnic Nerves; Tyrosine 3-Monooxygenase

1989
Cross-tolerance of dopamine metabolism to baclofen, gamma-butyrolactone and HA-966 in the striatum and olfactory tubercle of the rat.
    Life sciences, 1981, Mar-02, Volume: 28, Issue:9

    Topics: 4-Butyrolactone; Animals; Apomorphine; Baclofen; Central Nervous System Depressants; Corpus Striatum; Dopamine; Drug Tolerance; Male; Olfactory Bulb; Pyrrolidinones; Rats

1981
Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats.
    Brain research, 1998, Jan-19, Volume: 781, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine Agonists; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Haloperidol; Hyperkinesis; Male; Motor Activity; Phencyclidine; Pyrrolidinones; Rats; Rats, Wistar; Reflex, Startle; Strychnine

1998
Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent, S(-)HA-966 without affecting the basal firing properties of dopamine neurons.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 21, Issue:5

    Topics: Action Potentials; Animals; Apomorphine; Denervation; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; GABA-B Receptor Antagonists; Haloperidol; Male; Neurons; Pertussis Toxin; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Substantia Nigra; Virulence Factors, Bordetella

1999